Clinical trials
Carcinoma, Ductal, Breast trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| American College of Radiology Imaging Network | 1 |
| Cancer Trials Ireland | 1 |
| Case Comprehensive Cancer Center | 1 |
| Centre Leon Berard | 1 |
| City of Hope Medical Center | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Kantonsspital Winterthur KSW | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ductal, Breast | 23 |
| Breast Neoplasms | 16 |
| Carcinoma, Intraductal, Noninfiltrating | 9 |
| Carcinoma, Lobular | 5 |
| Breast Carcinoma In Situ | 4 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Gastrointestinal Neoplasms | 1 |
| Melanoma | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.